Condition: Muscle Atrophy · Sponsor: Immunis, Inc.
An open-label dose escalation study to assess the safety and tolerability of IMM01-STEM in participants with muscle atrophy related to knee osteoarthritis
This description comes directly from the study's public registry record.
Joelle Hafen, BS · 9492662501 · Joelle@immunisbiomedical.com
Erin Curry, PA · 9492662501 · Erin@immunisbiomedical.com
Always discuss trial participation with your own doctor first.
| Orthopaedic Specialty Institute | Irvine, California, United States | Recruiting |
| University of California, Irvine - Alpha Stem Cell Clinic | Orange, California, United States | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05211986